Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Pierre Fabre Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (29)
ARTG (27)
Prescription medicine registration (3)
Prescription medicine evaluation (2)
Australian public assessment report (AusPar) (1)
Designation or determination (1)

Date

2025 (16)
2024 (4)
2023 (7)
2022 (9)
2021 (4)
2020 (6)
2019 (3)
2018 (2)
2017 (4)
2015 (4)
2005 (2)
1998 (2)

Search

Sponsor content

63 result(s) found, displaying 11 to 20

VINORELBINE PIERRE FABRE vinorelbine 30mg (as tartrate) capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2025

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
VINORELBINE PIERRE FABRE vinorelbine 20mg (as tartrate) capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2025

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
VINORELBINE PIERRE FABRE vinorelbine 50mg/5mL (as tartrate) injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2025

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
VINORELBINE PIERRE FABRE vinorelbine 10mg/mL (as tartrate) injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2025

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
SUNSITIVE® OIL CONTROL SUNSCREEN FLUID SPF50+ (472572)

11 December 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SUNSITIVE® OIL CONTROL SUNSCREEN FLUID SPF50+.
CICALFATE+ MULTI PROTECTIVE RESTORATIVE CREAM SPF50+ (469605)

20 November 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CICALFATE+ MULTI PROTECTIVE RESTORATIVE CREAM SPF50+.
Pierre Fabre Patient Skin Kit (463900)

8 October 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Pierre Fabre Patient Skin Kit.
Pierre Fabre Patient Support Pack (462076)

9 September 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Pierre Fabre Patient Support Pack.
BRAFTOVI Pierre Fabre Australia Pty Ltd

Mar-2025

Prescription medicine evaluation

Active ingredient: encorafenib.
MEKTOVI Pierre Fabre Australia Pty Ltd

Mar-2025

Prescription medicine evaluation

Active ingredient: binimetinib.

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.